China Innovation Investment Limited (HK:1217)
:1217
Want to see HK:1217 full AI Analyst Report?
Top Page
China Innovation Investment Limited
(1217)
Select Model
Select Model
Rating:67Neutral
Price Target:
HK$0.01
▲(30.00% Upside)
Action:Reiterated
Date:05/12/26
The score is driven primarily by solid underlying financial positioning (notably a very conservative balance sheet) and a strong 2025 profitability rebound, offset by a sharp drop in 2025 cash flow quality. Technicals add caution due to negative MACD and price sitting below the 200-day average, while valuation is supportive given the very low P/E.
Positive Factors
Conservative balance sheet
The company's extremely low leverage and large equity base provide durable financial resilience and flexibility. Over a 2–6 month horizon this conservatism reduces downside risk, preserves borrowing optionality for opportunities or stress, and supports strategic choices without forcing asset sales.
Negative Factors
Cash flow deterioration
A swing to negative operating cash flow and zero free cash flow in 2025 materially weakens earnings quality and financial flexibility. Over months this can constrain reinvestment, dividends or working capital, and may force reliance on external funding despite recent profit improvement, raising sustainability concerns.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
The company's extremely low leverage and large equity base provide durable financial resilience and flexibility. Over a 2–6 month horizon this conservatism reduces downside risk, preserves borrowing optionality for opportunities or stress, and supports strategic choices without forcing asset sales.
Read all positive factors
China Innovation Investment Limited (1217) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$153.62M
Dividend YieldN/A
Average Volume (3M)29.68M
Price to Earnings (P/E)2.9
Beta (1Y)1.29
Revenue Growth211.60%
EPS Growth1000.00%
CountryHK
Employees16
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)<0.01
Shares Outstanding12,801,579,000
10 Day Avg. Volume57,745,200
30 Day Avg. Volume29,677,520
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.28
Price to Sales (P/S)2.58
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
China Innovation Investment Limited Business Overview & Revenue Model
Company Description
China Innovation Investment Limited invests in equity-related securities and debt instruments in listed and unlisted companies in Hong Kong and the People's Republic of China. It also engages in transactions comprising options and futures that are...
How the Company Makes Money
null...
China Innovation Investment Limited Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
88
Very Positive
Cash Flow
45
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 64.56M | 20.26M | 3.12M | 34.38M | -26.73M |
| Gross Profit | 62.55M | 20.26M | 9.53M | 12.16M | -27.62M |
| EBITDA | 57.65M | 5.91M | 3.24M | 6.64M | -32.94M |
| Net Income | 56.67M | 5.00M | 2.19M | 5.76M | -34.01M |
Balance Sheet | |||||
| Total Assets | 703.09M | 548.58M | 550.22M | 564.03M | 612.68M |
| Cash, Cash Equivalents and Short-Term Investments | 274.77M | 299.84M | 177.96M | 137.63M | 156.54M |
| Total Debt | 474.00K | 1.38M | 2.23M | 475.00K | 1.39M |
| Total Liabilities | 102.17M | 5.87M | 2.55M | 770.00K | 1.68M |
| Stockholders Equity | 600.92M | 542.71M | 547.67M | 563.26M | 611.00M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 178.84M | 28.56M | -15.37M | -19.35M |
| Operating Cash Flow | -37.80M | 178.84M | 28.62M | -14.95M | -19.35M |
| Investing Cash Flow | -50.00M | -4.97M | 6.18M | 9.14M | 16.79M |
| Financing Cash Flow | -907.00K | -854.00K | -883.00K | -915.00K | -871.00K |
China Innovation Investment Limited Technical Analysis
Negative
0.01
Price Trends
0.01
Negative
0.01
Negative
0.01
Negative
Market Momentum
>-0.01
Negative
48.11
Neutral
-100.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1217, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.01, below the 50-day MA of 0.01, and below the 200-day MA of 0.01, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.11 is Neutral, neither overbought nor oversold. The STOCH value of -100.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1217.
China Innovation Investment Limited Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$153.62M | 2.94 | 9.71% | ― | 211.60% | 1000.00% | |
62 Neutral | HK$2.03B | 6.69 | 1.10% | ― | -7.70% | 101.92% | |
55 Neutral | HK$383.71M | 0.58 | 65.61% | ― | 35.11% | ― | |
47 Neutral | HK$718.85M | -6.34 | -20.05% | ― | -89.75% | -12.43% | |
41 Neutral | HK$53.30M | -0.40 | -62.39% | ― | -26.78% | -166.41% | |
40 Underperform | HK$523.08M | -12.45 | -22.40% | ― | -166.78% | 85.53% |
* Financial Sector Average
HK:1217
China Innovation Investment Limited
0.01
<0.01
20.00%
HK:0204
China Investment Development Limited
0.21
-0.85
-79.81%
HK:1140
Wealthking Investments Limited
0.17
0.10
123.08%
HK:1226
China Investment and Finance Group Ltd
0.93
0.12
14.81%
HK:0612
China Investment Fund Company Limited
0.34
0.12
55.09%
HK:0080
China New Economy Fund Ltd.
0.33
0.27
459.32%
China Innovation Investment Limited Corporate Events
China Innovation Investment Calls 2026 AGM, Seeks Share Buyback and Issuance Mandates
Apr 28, 2026
China Innovation Investment Limited has convened its annual general meeting for 29 May 2026 in Hong Kong, where shareholders will review the audited financial statements for the year ended 31 December 2025 and consider the re-election of retiring ...
China Innovation Investment Updates Net Asset Value Per Share
Apr 14, 2026
China Innovation Investment Limited reported that its unaudited net asset value per share stood at approximately HK$0.045 as of 31 March 2026. The disclosure provides investors with an updated gauge of the company’s per-share asset backing, ...
China Innovation Investment Posts Strong 2025 Profit on Higher Investment Gains
Mar 24, 2026
China Innovation Investment Limited reported a sharp increase in turnover to about HK$2.18 billion for 2025 from HK$687.88 million in 2024, reflecting significantly higher investment activity. Net realised gains on disposal of investments at fair ...
China Innovation Investment Updates Unaudited Net Asset Value Per Share
Mar 13, 2026
China Innovation Investment Limited reported that its unaudited net asset value per share stood at approximately HK$0.047 as of 28 February 2026, providing investors with an updated snapshot of the company’s balance-sheet strength. The discl...
China Innovation Investment Sets March Board Meeting to Approve 2025 Results
Mar 6, 2026
China Innovation Investment Limited has scheduled a board meeting for 24 March 2026 to review and approve the company’s final results for the financial year ended 31 December 2025. The board will also consider the declaration of a dividend, ...
China Innovation Investment Flags Tenfold Profit Jump on Strong Market Gains
Mar 2, 2026
China Innovation Investment Limited has issued a positive profit alert, indicating that it expects to report a net profit of about HK$57 million for 2025, a surge of roughly 1,040% from HK$5 million in 2024. The sharp improvement is mainly attribu...
China Innovation Investment Updates Unaudited Net Asset Value per Share
Feb 13, 2026
China Innovation Investment Limited reported that its unaudited net asset value per share stood at approximately HK$0.047 as of 31 January 2026, providing investors with an updated snapshot of the company’s underlying asset base on a per-sha...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.